메뉴 건너뛰기




Volumn 75, Issue 10, 2015, Pages 2017-2028

Oncogenic HRAS activates epithelial-to-mesenchymal transition and confers stemness to p53-deficient urothelial cells to drive muscle invasion of basal subtype carcinomas

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P19; PROTEIN P21; PROTEIN P53; TRANSCRIPTOME; KRAS2 PROTEIN, MOUSE; MATRIX METALLOPROTEINASE;

EID: 84942934311     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3067     Document Type: Article
Times cited : (25)

References (55)
  • 1
    • 70149120096 scopus 로고    scopus 로고
    • Key concerns about the current state of bladder cancer: A position paper from the bladder cancer ThinkTank, the bladder cancer advocacy network, and the society of urologic oncology
    • Lotan Y, Kamat AM, Porter MP, Robinson VL, Shore N, Jewett M, et al. Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer ThinkTank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology. Cancer 2009;115:4096-103.
    • (2009) Cancer , vol.115 , pp. 4096-4103
    • Lotan, Y.1    Kamat, A.M.2    Porter, M.P.3    Robinson, V.L.4    Shore, N.5    Jewett, M.6
  • 2
    • 84890661634 scopus 로고    scopus 로고
    • Pharmacogenomics in bladder cancer
    • Dancik GM, Theodorescu D. Pharmacogenomics in bladder cancer. Urol Oncol 2014;32:16-22.
    • (2014) Urol Oncol , vol.32 , pp. 16-22
    • Dancik, G.M.1    Theodorescu, D.2
  • 3
    • 84864423349 scopus 로고    scopus 로고
    • A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer
    • Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol 2012;62:523-33.
    • (2012) Eur Urol , vol.62 , pp. 523-533
    • Meeks, J.J.1    Bellmunt, J.2    Bochner, B.H.3    Clarke, N.W.4    Daneshmand, S.5    Galsky, M.D.6
  • 4
    • 84893520397 scopus 로고    scopus 로고
    • Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy
    • Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 2014;25:152-65.
    • (2014) Cancer Cell , vol.25 , pp. 152-165
    • Choi, W.1    Porten, S.2    Kim, S.3    Willis, D.4    Plimack, E.R.5    Hoffman-Censits, J.6
  • 6
    • 84893547604 scopus 로고    scopus 로고
    • Molecular subtyping of invasive bladder cancer: Time to divide and rule?
    • Hurst CD, Knowles MA. Molecular subtyping of invasive bladder cancer: time to divide and rule? Cancer Cell 2014;25:135-6.
    • (2014) Cancer Cell , vol.25 , pp. 135-136
    • Hurst, C.D.1    Knowles, M.A.2
  • 7
    • 84857748705 scopus 로고    scopus 로고
    • Combination of a novel gene expression signature with a clinical nomo-gram improves the prediction of survival in high-risk bladder cancer
    • Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ, et al. Combination of a novel gene expression signature with a clinical nomo-gram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res 2012;18:1323-33.
    • (2012) Clin Cancer Res , vol.18 , pp. 1323-1333
    • Riester, M.1    Taylor, J.M.2    Feifer, A.3    Koppie, T.4    Rosenberg, J.E.5    Downey, R.J.6
  • 8
    • 84908460595 scopus 로고    scopus 로고
    • Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
    • Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014;158:929-44.
    • (2014) Cell , vol.158 , pp. 929-944
    • Hoadley, K.A.1    Yau, C.2    Wolf, D.M.3    Cherniack, A.D.4    Tamborero, D.5    Ng, S.6
  • 11
    • 35348887132 scopus 로고    scopus 로고
    • Persistent uroplakin expression in advanced urothelial carcinomas: Implications in urothelial tumor progression and clinical outcome
    • Huang HY, Shariat SF, Sun TT, Lepor H, Shapiro E, Hsieh JT, et al. Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome. Hum Pathol 2007;38: 1703-13.
    • (2007) Hum Pathol , vol.38 , pp. 1703-1713
    • Huang, H.Y.1    Shariat, S.F.2    Sun, T.T.3    Lepor, H.4    Shapiro, E.5    Hsieh, J.T.6
  • 12
    • 84887053305 scopus 로고    scopus 로고
    • Accelerating cancer modeling with RNAi and non-germline genetically engineered mouse models
    • Livshits G, Lowe SW. Accelerating cancer modeling with RNAi and non-germline genetically engineered mouse models. Cold Spring Harbor protocols 2013;2013.
    • (2013) Cold Spring Harbor Protocols , pp. 2013
    • Livshits, G.1    Lowe, S.W.2
  • 13
    • 25444467767 scopus 로고    scopus 로고
    • Urothelial tumorigenesis: A tale of divergent pathways
    • Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005;5:713-25.
    • (2005) Nat Rev Cancer , vol.5 , pp. 713-725
    • Wu, X.R.1
  • 15
    • 0030277564 scopus 로고    scopus 로고
    • Superficial bladder cancer: Decreasing the risk of recurrence
    • Grossman HB. Superficial bladder cancer: decreasing the risk of recurrence. Oncology (Huntingt) 1996;10:1617-24.
    • (1996) Oncology (Huntingt) , vol.10 , pp. 1617-1624
    • Grossman, H.B.1
  • 18
    • 84884154555 scopus 로고    scopus 로고
    • Retinoid signaling in progenitors controls specificationand regeneration of the urothelium
    • Gandhi D, Molotkov A, Batourina E, Schneider K, Dan H, Reiley M, et al. Retinoid signaling in progenitors controls specificationand regeneration of the urothelium. Dev Cell 2013;26:469-82.
    • (2013) Dev Cell , vol.26 , pp. 469-482
    • Gandhi, D.1    Molotkov, A.2    Batourina, E.3    Schneider, K.4    Dan, H.5    Reiley, M.6
  • 20
    • 84899953445 scopus 로고    scopus 로고
    • Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma
    • Shin K, Lim A, Odegaard JI, Honeycutt JD, Kawano S, Hsieh MH, et al. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma. Nat Cell Biol 2014;16:469-78.
    • (2014) Nat Cell Biol , vol.16 , pp. 469-478
    • Shin, K.1    Lim, A.2    Odegaard, J.I.3    Honeycutt, J.D.4    Kawano, S.5    Hsieh, M.H.6
  • 21
    • 27744541445 scopus 로고    scopus 로고
    • Mechanisms of disease: Genetic and epigenetic alterations that drive bladder cancer
    • Wolff EM, Liang G, Jones PA. Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol 2005;2: 502-10.
    • (2005) Nat Clin Pract Urol , vol.2 , pp. 502-510
    • Wolff, E.M.1    Liang, G.2    Jones, P.A.3
  • 22
    • 1542405934 scopus 로고    scopus 로고
    • FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma
    • van Rhijn BW, van der Kwast TH, Vis AN, Kirkels WJ, Boeve ER, Jobsis AC, et al. FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma. Cancer Res 2004;64: 1911-4.
    • (2004) Cancer Res , vol.64 , pp. 1911-1914
    • Van Rhijn, B.W.1    Van Der Kwast, T.H.2    Vis, A.N.3    Kirkels, W.J.4    Boeve, E.R.5    Jobsis, A.C.6
  • 23
    • 84897022815 scopus 로고    scopus 로고
    • Comprehensive molecular characterization of urothelial bladder carcinoma
    • Network TCGAR. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014;507:315-22.
    • (2014) Nature , vol.507 , pp. 315-322
    • Network TCGAR1
  • 24
    • 33846839630 scopus 로고    scopus 로고
    • Hyperactivation of ha-ras oncogene, but not ink4a/Arf deficiency, triggers bladder tumorigenesis
    • Mo L, Zheng X, Huang HY, Shapiro E, Lepor H, Cordon-Cardo C, et al. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis. J Clin Invest 2007;117:314-25.
    • (2007) J Clin Invest , vol.117 , pp. 314-325
    • Mo, L.1    Zheng, X.2    Huang, H.Y.3    Shapiro, E.4    Lepor, H.5    Cordon-Cardo, C.6
  • 25
    • 23944482077 scopus 로고    scopus 로고
    • Gene deletion in urothelium by specific expression of cre recombinase
    • Mo L, Cheng J, Lee EY, Sun TT, Wu XR. Gene deletion in urothelium by specific expression of Cre recombinase. Am J Physiol Renal Physiol 2005; 289:F562-8.
    • (2005) Am J Physiol Renal Physiol , vol.289 , pp. F562-F568
    • Mo, L.1    Cheng, J.2    Lee, E.Y.3    Sun, T.T.4    Wu, X.R.5
  • 26
    • 73649147076 scopus 로고    scopus 로고
    • Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis
    • He F, Mo L, Zheng XY, Hu C, Lepor H, Lee EY, et al. Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis. Cancer Res 2009; 69:9413-21.
    • (2009) Cancer Res , vol.69 , pp. 9413-9421
    • He, F.1    Mo, L.2    Zheng, X.Y.3    Hu, C.4    Lepor, H.5    Lee, E.Y.6
  • 27
    • 0014913045 scopus 로고
    • A human tissue culture cell line from a transitional cell tumour of the urinary bladder: Growth, chromosone pattern and ultrastructure
    • Rigby CC, Franks LM. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br J Cancer 1970;24:746-54.
    • (1970) Br J Cancer , vol.24 , pp. 746-754
    • Rigby, C.C.1    Franks, L.M.2
  • 28
    • 0035810054 scopus 로고    scopus 로고
    • Regulation of the G2/M transition by p53
    • Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001;20:1803-15.
    • (2001) Oncogene , vol.20 , pp. 1803-1815
    • Taylor, W.R.1    Stark, G.R.2
  • 29
    • 0032190629 scopus 로고    scopus 로고
    • Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
    • Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998;12:3008-19.
    • (1998) Genes Dev , vol.12 , pp. 3008-3019
    • Lin, A.W.1    Barradas, M.2    Stone, J.C.3    Van Aelst, L.4    Serrano, M.5    Lowe, S.W.6
  • 31
    • 33947407269 scopus 로고    scopus 로고
    • Investigations of rodent urinary bladder carcinogens: Collection, processing, and evaluation of urine and bladders
    • Cohen SM, Ohnishi T, Clark NM, He J, Arnold LL. Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders. Toxicol Pathol 2007;35:337-47.
    • (2007) Toxicol Pathol , vol.35 , pp. 337-347
    • Cohen, S.M.1    Ohnishi, T.2    Clark, N.M.3    He, J.4    Arnold, L.L.5
  • 34
    • 69549114870 scopus 로고    scopus 로고
    • Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
    • Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A 2009;106:14016-21.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 14016-14021
    • Chan, K.S.1    Espinosa, I.2    Chao, M.3    Wong, D.4    Ailles, L.5    Diehn, M.6
  • 35
    • 76649134077 scopus 로고    scopus 로고
    • Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
    • McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009;28:335-44.
    • (2009) Cancer Metastasis Rev , vol.28 , pp. 335-344
    • McConkey, D.J.1    Choi, W.2    Marquis, L.3    Martin, F.4    Williams, M.B.5    Shah, J.6
  • 36
  • 38
    • 84885735554 scopus 로고    scopus 로고
    • Mutational landscape and significance across 12 major cancer types
    • Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502:333-9.
    • (2013) Nature , vol.502 , pp. 333-339
    • Kandoth, C.1    McLellan, M.D.2    Vandin, F.3    Ye, K.4    Niu, B.5    Lu, C.6
  • 39
    • 79959643392 scopus 로고    scopus 로고
    • K-ras and beta-cateninmutations cooperate with fgfr3 mutationsinmicetopromote tumorigenesisintheskin and lung, but notinthe bladder
    • Ahmad I, Singh LB, Foth M, Morris CA, Taketo MM, Wu XR, et al. K-Ras and beta-cateninmutations cooperate with Fgfr3 mutationsinmicetopromote tumorigenesisintheskin and lung, but notinthe bladder. Dis Model Mech 2011;4:548-55.
    • (2011) Dis Model Mech , vol.4 , pp. 548-555
    • Ahmad, I.1    Singh, L.B.2    Foth, M.3    Morris, C.A.4    Taketo, M.M.5    Wu, X.R.6
  • 40
    • 0037099540 scopus 로고    scopus 로고
    • Over-expression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth
    • Cheng J, Huang H, Zhang ZT, Shapiro E, Pellicer A, Sun TT, et al. Over-expression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res 2002;62:4157-63.
    • (2002) Cancer Res , vol.62 , pp. 4157-4163
    • Cheng, J.1    Huang, H.2    Zhang, Z.T.3    Shapiro, E.4    Pellicer, A.5    Sun, T.T.6
  • 41
    • 33644868287 scopus 로고    scopus 로고
    • Molecular subtypes of bladder cancer: Jekyll and hyde or chalk and cheese?
    • Knowles MA. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 2006;27:361-73.
    • (2006) Carcinogenesis , vol.27 , pp. 361-373
    • Knowles, M.A.1
  • 42
    • 2342477248 scopus 로고    scopus 로고
    • Tumor suppressor genes of bladder cancer and potential for gene therapy
    • Tanaka M, Grossman HB. Tumor suppressor genes of bladder cancer and potential for gene therapy. Adv Exp Med Biol 2003;539(Pt A):185-91.
    • (2003) Adv Exp Med Biol , vol.539 , pp. 185-191
    • Tanaka, M.1    Grossman, H.B.2
  • 43
    • 84897073946 scopus 로고    scopus 로고
    • Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder
    • Xylinas E, Kluth LA, Lotan Y, Daneshmand S, Rieken M, Karakiewicz PI, et al. Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder. Urol Oncol 2014;32:230-42.
    • (2014) Urol Oncol , vol.32 , pp. 230-242
    • Xylinas, E.1    Kluth, L.A.2    Lotan, Y.3    Daneshmand, S.4    Rieken, M.5    Karakiewicz, P.I.6
  • 44
    • 68949183335 scopus 로고    scopus 로고
    • Potential new urinary markers in the early detection of bladder cancer
    • Shirodkar SP, Lokeshwar VB. Potential new urinary markers in the early detection of bladder cancer. Curr Opin Urol 2009;19:488-93.
    • (2009) Curr Opin Urol , vol.19 , pp. 488-493
    • Shirodkar, S.P.1    Lokeshwar, V.B.2
  • 45
    • 80052737876 scopus 로고    scopus 로고
    • Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status
    • Stadler WM, Lerner SP, Groshen S, Stein JP, Shi SR, Raghavan D, et al. Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. J Clin Oncol 2011; 29:3443-9.
    • (2011) J Clin Oncol , vol.29 , pp. 3443-3449
    • Stadler, W.M.1    Lerner, S.P.2    Groshen, S.3    Stein, J.P.4    Shi, S.R.5    Raghavan, D.6
  • 46
    • 0037228782 scopus 로고    scopus 로고
    • Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder
    • Cheng J, Huang H, Pak J, Shapiro E, Sun TT, Cordon-Cardo C, et al. Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder. Cancer Res 2003;63: 179-85.
    • (2003) Cancer Res , vol.63 , pp. 179-185
    • Cheng, J.1    Huang, H.2    Pak, J.3    Shapiro, E.4    Sun, T.T.5    Cordon-Cardo, C.6
  • 47
    • 1242318513 scopus 로고    scopus 로고
    • p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis
    • Gao J, Huang HY, Pak J, Cheng J, Zhang ZT, Shapiro E, et al. p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. Oncogene 2004;23:687-96.
    • (2004) Oncogene , vol.23 , pp. 687-696
    • Gao, J.1    Huang, H.Y.2    Pak, J.3    Cheng, J.4    Zhang, Z.T.5    Shapiro, E.6
  • 50
    • 84859601315 scopus 로고    scopus 로고
    • Urothelial tumor initiation requires deregulation of multiple signaling pathways: Implications in target-based therapies
    • Zhou H, Huang HY, Shapiro E, Lepor H, Huang WC, Mohammadi M, et al. Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies. Carcinogenesis 2012; 33:770-80.
    • (2012) Carcinogenesis , vol.33 , pp. 770-780
    • Zhou, H.1    Huang, H.Y.2    Shapiro, E.3    Lepor, H.4    Huang, W.C.5    Mohammadi, M.6
  • 51
    • 84885427983 scopus 로고    scopus 로고
    • The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis
    • Evangelou K, Bartkova J, Kotsinas A, Pateras IS, Liontos M, Velimezi G, et al. The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis. Cell Death Differ 2013; 20:1485-97.
    • (2013) Cell Death Differ , vol.20 , pp. 1485-1497
    • Evangelou, K.1    Bartkova, J.2    Kotsinas, A.3    Pateras, I.S.4    Liontos, M.5    Velimezi, G.6
  • 52
    • 84907445756 scopus 로고    scopus 로고
    • Molecular pathways: Targeting RAC-p21-activated serine-threonine kinase signaling in RAS-driven cancers
    • Baker NM, Yee Chow H, Chernoff J, Der CJ. Molecular pathways: targeting RAC-p21-activated serine-threonine kinase signaling in RAS-driven cancers. Clin Cancer Res 2014;20:4740-6.
    • (2014) Clin Cancer Res , vol.20 , pp. 4740-4746
    • Baker, N.M.1    Yee Chow, H.2    Chernoff, J.3    Der, C.J.4
  • 53
    • 78951475020 scopus 로고    scopus 로고
    • p53 and its mutants in tumor cell migration and invasion
    • Muller PA, Vousden KH, Norman JC. p53 and its mutants in tumor cell migration and invasion. J Cell Biol 2011;192:209-18.
    • (2011) J Cell Biol , vol.192 , pp. 209-218
    • Muller, P.A.1    Vousden, K.H.2    Norman, J.C.3
  • 54
    • 42649137241 scopus 로고    scopus 로고
    • Mechanisms of disease: Epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression?
    • Turley EA, Veiseh M, Radisky DC, Bissell MJ. Mechanisms of disease: epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 2008;5:280-90.
    • (2008) Nat Clin Pract Oncol , vol.5 , pp. 280-290
    • Turley, E.A.1    Veiseh, M.2    Radisky, D.C.3    Bissell, M.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.